Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2022-03-28 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - AVR 5 pages 25.6KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the expiry of options and convertible securities for Anteris Technologies Ltd. It provides specific information about securities that have ceased, including ASX security codes, descriptions, numbers, and reasons for cessation. The document is a formal announcement about changes in the company's issued capital due to expiry of securities. It does not contain financial statements, management discussion, or detailed financial results. It is not an annual or interim report, nor an earnings release or audit report. It is also not a regulatory certification or legal proceeding. The content fits best with a Regulatory Filing (RNS) as it is a formal regulatory announcement about securities cessation that does not fit other more specific categories.
2022-03-28 English
Application for quotation of securities - AVR 8 pages 30.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the number of securities, issue dates, prices, and classifications of securities. There is no financial performance data, management discussion, or regulatory certification. The document is a formal announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. This fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive filing about capital changes.
2022-03-20 English
Cleansing Notice 2 pages 168.2KB
Share Issue/Capital Change Classification · 95% confidence The document is an ASX announcement dated 14 March 2022 regarding the issuance of 6,000 new fully paid ordinary shares following the conversion of unlisted options. It references compliance with section 708A(5)(e) of the Corporations Act 2001, which relates to share issuance notices and cleansing notices for securities issued without disclosure under Part 6D.2 of the Corporations Act. The document is short (2992 characters) and primarily serves as a formal notice of a share issue event rather than a detailed financial report or capital raising update. It does not contain comprehensive financial data or analysis, nor does it announce a report publication. The content fits best under the category of Share Issue/Capital Change announcements, which cover new share issues and related disclosures.
2022-03-13 English
Application for quotation of securities - AVR 8 pages 29.8KB
Capital/Financing Update Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary shares. It includes specifics about the number of securities, issue dates, and classifications. This type of document is related to changes in the company's capital structure, specifically the issuance and quotation of new shares resulting from option exercises. It is not a financial report, earnings release, or management discussion, nor is it a regulatory announcement about voting or board changes. The content fits the category of Capital/Financing Update, as it concerns securities issuance and quotation on the exchange.
2022-03-10 English
Notification of cessation of securities - AVR 5 pages 26.2KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options and securities for Anteris Technologies Ltd. It provides specific information about securities that have ceased, reasons for cessation, and updated issued capital figures. There is no indication of financial statements, management discussion, or earnings data. The document is an announcement about changes in the company's securities, specifically the cessation of certain securities. This fits the category of Regulatory Filings (RNS) as it is a regulatory announcement about securities status changes and does not fit into more specific categories like Capital/Financing Update or Share Issue/Capital Change, which typically involve new issuances or capital structure changes rather than cessation notifications. The document length is 5521 characters, which is sufficient for a detailed announcement but does not contain financial reports or presentations. Therefore, the best classification is Regulatory Filings (RNS).
2022-03-10 English
Change of Director's Interest Notice 3 pages 269.5KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in securities holdings by a company director, including number of shares held before and after the change, nature of the interest, and transaction details. This matches the definition of a Director's Dealing report, which involves reporting personal share transactions by company directors and executives. The document length is 3645 characters, which is typical for such notices. There is no indication that this is an announcement of a report or a certification, so it is not Regulatory Filings or Report Publication Announcement. Therefore, the correct classification is Director's Dealing (DIRS).
2022-03-08 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.